BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33551318)

  • 1. Neuroendocrine Carcinoma of the Anus and Rectum: Patient Characteristics and Treatment Options.
    Ueberroth BE; Liu AJ; Starr JS; Hobday TJ; Ashman JB; Mishra N; Bekaii-Saab TS; Halfdanarson TR; Sonbol MB
    Clin Colorectal Cancer; 2021 Jun; 20(2):e139-e149. PubMed ID: 33551318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term outcomes of neuroendocrine carcinomas (high-grade neuroendocrine tumors) of the colon, rectum, and anal canal.
    Aytac E; Ozdemir Y; Ozuner G
    J Visc Surg; 2014 Feb; 151(1):3-7. PubMed ID: 24412088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal Canal.
    Voong KR; Rashid A; Crane CH; Minsky BD; Krishnan S; Yao JC; Wolff RA; Skibber JM; Feig BW; Chang GJ; Das P
    Am J Clin Oncol; 2017 Dec; 40(6):555-560. PubMed ID: 26237193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus.
    Maru DM; Khurana H; Rashid A; Correa AM; Anandasabapathy S; Krishnan S; Komaki R; Ajani JA; Swisher SG; Hofstetter WL
    Am J Surg Pathol; 2008 Sep; 32(9):1404-11. PubMed ID: 18670347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National Cancer Database Study.
    Alese OB; Jiang R; Shaib W; Wu C; Akce M; Behera M; El-Rayes BF
    Oncologist; 2019 Jul; 24(7):911-920. PubMed ID: 30482824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiochemotherapy Versus Surgery in Nonmetastatic Anorectal Neuroendocrine Carcinoma: A Multicenter Study by the Association des Gastro-Entérologues Oncologues.
    Brieau B; Lepère C; Walter T; Lecomte T; Guimbaud R; Manfredi S; Tougeron D; Desseigne F; Lourenco N; Afchain P; El Hajbi F; Terris B; Rougier P; Coriat R
    Medicine (Baltimore); 2015 Oct; 94(42):e1864. PubMed ID: 26496341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and Characterization of a Novel Cell Line Derived from a Small Cell Neuroendocrine Carcinoma of the Anal Canal.
    Dizdar L; Drusenheimer J; Werner TA; Möhlendick B; Schütte SC; Esposito I; Filler TJ; Knoefel WT; Krieg A
    Neuroendocrinology; 2018; 107(3):246-256. PubMed ID: 30025411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes and prognostic factors in neuroendocrine carcinomas of the pancreas: Morphology matters.
    Crippa S; Partelli S; Bassi C; Berardi R; Capelli P; Scarpa A; Zamboni G; Falconi M
    Surgery; 2016 Mar; 159(3):862-71. PubMed ID: 26602841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine Carcinoma of Gall Bladder: A Series of 19 Cases with Review of Literature.
    Kamboj M; Gandhi JS; Gupta G; Sharma A; Pasricha S; Mehta A; Chandragouda D; Sinha R
    J Gastrointest Cancer; 2015 Dec; 46(4):356-64. PubMed ID: 26208508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poorer prognosis for neuroendocrine carcinoma than signet ring cell cancer of the colon and rectum (CRC-NEC): a propensity score matching analysis of patients from the Surveillance, Epidemiology, and End Results (SEER) database.
    Chen Y; Tu J; Zhou S; Fu J; Wang Q
    Int J Colorectal Dis; 2021 Apr; 36(4):745-756. PubMed ID: 33415449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal.
    Eng C; Chang GJ; You YN; Das P; Xing Y; Delclos M; Wolff RA; Rodriguez-Bigas MA; Skibber J; Ohinata A; Gould S; Phillips J; Crane CH
    Cancer; 2013 Nov; 119(21):3769-75. PubMed ID: 24037775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical diagnosis and treatment of 37 cases of gallbladder neuroendocrine carcinoma.
    Liu F; Miao W; Nan J; Shi Z; Zhang A; Bo Y; Xu J
    World J Surg Oncol; 2024 Jun; 22(1):157. PubMed ID: 38877554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network.
    Hadoux J; Kanaan C; Durand A; Hescot S; Hautefeuille V; Cadiot G; Tauveron I; Laboureau S; Do Cao C; Walter T; Petorin C; Blanchet O; Jannin A; Gu C; Faron M; Leteurtre E; Rousselet MC; Zakeyh JJ; Marchal A; Chatelain D; Beaulaton C; Hervieu V; Ducreux M; Scoazec JY; Baudin E
    Eur J Cancer; 2021 Jul; 152():100-115. PubMed ID: 34090142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas.
    Liu DJ; Fu XL; Liu W; Zheng LY; Zhang JF; Huo YM; Li J; Hua R; Liu Q; Sun YW
    World J Gastroenterol; 2017 Jan; 23(3):516-524. PubMed ID: 28210088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary surgery with or without postoperative radiotherapy in early stage squamous cell carcinoma in the anal canal and anal margin.
    Leon O; Hagberg O; Johnsson A
    Acta Oncol; 2018 Sep; 57(9):1209-1215. PubMed ID: 29490558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: A SEER database analysis of 162,983 cases.
    Dasari A; Mehta K; Byers LA; Sorbye H; Yao JC
    Cancer; 2018 Feb; 124(4):807-815. PubMed ID: 29211313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy.
    Mitra D; Horick NK; Brackett DG; Mouw KW; Hornick JL; Ferrone S; Hong TS; Mamon H; Clark JW; Parikh AR; Allen JN; Ryan DP; Ting DT; Deshpande V; Wo JY
    Oncologist; 2019 Jun; 24(6):e275-e283. PubMed ID: 30755500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal Therapy of Squamous Cell Carcinoma of the Anus With Distant Metastasis: A Single-Institution Experience.
    Evesque L; Benezery K; Follana P; Tuan Falk A; Doyen J; Reure J; Cavaglione G; François E
    Dis Colon Rectum; 2017 Aug; 60(8):785-791. PubMed ID: 28682963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A twenty-year experience with adenocarcinoma of the anal canal.
    Chang GJ; Gonzalez RJ; Skibber JM; Eng C; Das P; Rodriguez-Bigas MA
    Dis Colon Rectum; 2009 Aug; 52(8):1375-80. PubMed ID: 19617747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinicopathologic Features and Treatment of 607 Hindgut Neuroendocrine Tumor (NET) Patients at a Single Institution.
    Kim ST; Ha SY; Lee J; Hong SN; Chang DK; Kim YH; Park YA; Huh JW; Cho YB; Yun SH; Lee WY; Kim HC; Park YS
    Medicine (Baltimore); 2016 May; 95(19):e3534. PubMed ID: 27175651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.